Contact

Representative before the EPO

Employment test 51 - 200 employees
Company dna boult wade tennant ltd
no operation time available
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Sharon Claire Baldock has worked on the following 13 EPO patent applications which have been published in the last five years:

EP12187075

Biomarker normalization

IPC classification:
G01N 13/04
Applicant:
The Regents of the University of California
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Agent:
Multiple attorneys, Fish & Richardson PC
Status:
EXAMINATION IN PROGRESS
EP11775656

ALLOPLASTIC INJECTABLE DERMAL FILLER AND METHODS OF USE THEREOF

IPC classification:
A61M 35/00
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12160605

Polymer-factor VIII moiety conjugates

IPC classification:
A61K 47/48
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
EXAMINATION REQUESTED
EP12160604

Polymer-factor VIII moiety conjugates

IPC classification:
A61K 47/48
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
EXAMINATION REQUESTED
EP11778725

METHODS FOR ASSESSING AND IDENTIFYING OR EVOLVING CONDITIONALLY ACTIVE THERAPEUTIC PROTEINS

IPC classification:
C07K 16/30, G01N 33/53, G01N 33/574, G01N 33/68
Applicant:
Halozyme Inc
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
EXAMINATION IN PROGRESS
EP12192296

Method for preparing of monodisperse oligo ethylene glycol

IPC classification:
A61K 47/48, C08G 65/329, C08G 65/337, C08G 65/34
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
GRANT OF PATENT INTENDED
EP13155667

OLIGOMER-OPIOID AGONIST CONJUGATES

IPC classification:
A61K 47/48
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
PATENT GRANTED
EP12811896

LIPID-CONTAINING PSA COMPOSITIONS, METHODS OF ISOLATION AND METHODS OF USE THEREOF

IPC classification:
A61K 31/715, A61K 35/74, A61P 29/00, C08B 37/00
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
GRANT OF PATENT INTENDED
EP13155670

Oligomer-opioid agonist conjugates

IPC classification:
A61K 47/48
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11749018

CYCLOSILOXANE-SUBSTITUTED POLYSILOXANE COMPOUNDS, COMPOSITIONS CONTAINING THE COMPOUNDS AND METHODS OF USE THEREOF

IPC classification:
C08G 77/50, C08L 83/14
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13152053

CD40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity

IPC classification:
A61K 39/245, A61K 39/285, A61K 39/39, A61K 47/48, A61K 48/00, C07K 14/555, C07K 14/705, C07K 16/28, C12N 1/20, C12N 5/10
Applicant:
The Regents of the University of Colorado
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11713391

NANOEMULSION INCLUDING SUCROSE FATTY ACID ESTER

IPC classification:
A61K 9/107, A23L 33/10, A23L 29/10, A23L 33/15
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
PATENT GRANTED
EP12188577

Emulsions including a PEG-derivative of tocopherol

IPC classification:
A23L 1/30, A61K 9/107, A61K 31/122, A61K 31/202
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature